Skip to main content
. Author manuscript; available in PMC: 2016 Oct 14.
Published in final edited form as: JAMA Psychiatry. 2015 Aug;72(8):822–829. doi: 10.1001/jamapsychiatry.2015.0270

Figure 2. Time to First Psychotic Exacerbation and/or Relapse as a Function of Form of Medication Administration in 83 Patients.

Figure 2

The risk of exacerbation and/or relapse over time was significantly lower for the long-acting injectable risperidone group than for the oral risperidone group. x Indicates censored data.